Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Interest Income - Total (2023 - 2025)

BioRestorative Therapies (BRTX) has disclosed Interest Income - Total for 3 consecutive years, with $59336.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Income - Total fell 64.13% year-over-year to $59336.0, compared with a TTM value of $367203.0 through Sep 2025, down 58.96%, and an annual FY2024 reading of $623801.0, up 9.62% over the prior year.
  • Interest Income - Total was $59336.0 for Q3 2025 at BioRestorative Therapies, down from $73743.0 in the prior quarter.
  • Across five years, Interest Income - Total topped out at $402202.0 in Q4 2023 and bottomed at -$39292.0 in Q3 2023.
  • Average Interest Income - Total over 3 years is $129886.1, with a median of $131325.0 recorded in 2024.
  • Peak annual rise in Interest Income - Total hit 520.98% in 2024, while the deepest fall reached 67.35% in 2024.
  • Year by year, Interest Income - Total stood at $402202.0 in 2023, then crashed by 67.35% to $131325.0 in 2024, then plummeted by 54.82% to $59336.0 in 2025.
  • Business Quant data shows Interest Income - Total for BRTX at $59336.0 in Q3 2025, $73743.0 in Q2 2025, and $102799.0 in Q1 2025.